GPCRs Cell-Based Assay Development

GPCRs Cell-Based Assay Development

For Research Use Only. Not For Clinical Use.

CD BioSciences provides fully assistance with cell-based assay development for GPCR research and drug development. With experienced scientific team and state-of-the-art platform, we can provide comprehensive services for the development and validation of a complete suite of cell-based assays.

Our experienced scientific team with a broad array of assay technologies can provide customized preclinical cell-based assay development services in a timely and cost-effective manner to support and accelerate cellular projects of our customers. Our cell-based assays can also be used in conjunction with high-throughput technology to assist drug screening and development.

Featured Technologies

Our professional scientific team has the expertise to recommend a technology from our extensive toolbox to best suit your unique requirements.

The following table lists our featured technologies. You can also send us an online inquiry to know more about other technologies that are not listed.

Technology Description
Cell engineering
  • Transient and stably transfection.
  • Comprehensive toolbox for cell engineering.
  • Efficient single cell cloning techniques.
  • Support GMP manufacturing assays.
  • 100% successful delivery track record.
  • Assay protocol is delivered simultaneously.
  • Rigorously QC tests.
Cell co-culture
  • Cell co-culture of multiple cell types in direct or indirect co-culture system.
  • Better mimic the microenvironment in vivo.
  • Better observation of cell-cell interaction and cell-to-cell communication.
  • Powerful tool to discover possible targets and reveal the mechanism of drugs.
3D Culture
  • Ready-to-use 3D cell culture models and optimized protocols.
  • Customized 3D cell culture services to meet specific needs.
  • Both mono-cell type and multi-cell type 3D cell culture models
  • Scaffold-based or scaffold-free 3D culture strategies.
  • Better mimic tissue-like structures.
  • Better mimic in vivo like microenvironments.
  • More accurate phenotype.
  • More accurately prediction of drug efficacy or toxicity.
  • Possible to stimulate microenvironment conditions.
  • Possible to replace several animal experiments to shorten the cycle of drug development.
Cell-based GPCR assays
  • Detection of multiple analytes involved in intracellular signaling pathways.
  • Complete experimental platform for GPCR research, including but not limited to second messenger assays, reporter assays, and binding assays.
  • Highly sensitivity and specific measures.
  • The most relevant biological assay and disease-relevant cells to meet specific research needs
  • Compatible with use in stable lines.
High-throughput screening / high-content screening
  • Combination of multidisciplinary knowledge and advanced technology.
  • More information from cellular samples and more meaningful results.
  • Automated analysis.
  • Powerful tool for drug discovery.

Our Process

Our cell-based assay development process – CD BioSciences

Our Advantages

  • Professional scientific team with extensive experience.
  • Extensive toolbox of cell-based assays.
  • Customized services to meet unique requirements.
  • Ideal partner for GPCR research and drug discovery.
  • Provide ongoing support during assay development.
  • Dedicated project management helps ensure all parties involved in the project are aligned on project requirements, timelines and budgets.
  • Quick turnaround time and competitive price.

CD BioSciences has experienced cell biologists and powerful resources to developing custom and precisely adapted cell-based assays to meet your unique requirements of GPCR research and drug development.

For more information on our cell-based assay development services, send us an inquiry online. If you have any specific needs, please feel free to contact us for more details.